Skip to content

Saturday, April 20, 2024

Latest:

When medicine becomes political
Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma
Collaborating with the community for autism research
Virtual education programs train clinicians around the world
First step to untangle DNA: capture gyrase like a lasso ropes cattle

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

HER2 gene

De-escalating breast cancer therapy; can some patients be spared chemotherapy?

June 25, 2019 Breast Cancer, Chemotherapy, Clinical Trials, HER2 gene, lapatinib, PI3K pathway, Research, trastuzumab

About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive

A new HER2 mutation leads to a clinical trial and to a promising diagnostic tool for metastatic breast cancer

July 27, 2017 circulating tumor DNA, clinical trial, HER2 gene, Metastatic breast cancer, neratinib

There is a group of metastatic breast cancers that has the HER2 gene amplified – the cells have many copies of it – which leads

From the Labs Image of the Month:

From the Labs: Human retinal organoid.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951